Vandetanib plus docetaxel versus docetaxel as second-line treatment for patients with advanced non-small-cell lung cancer (ZODIAC): a double-blind, randomised, phase 3 trial (Q35576189)
Jump to navigation
Jump to search
scientific article published on July 2010
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Vandetanib plus docetaxel versus docetaxel as second-line treatment for patients with advanced non-small-cell lung cancer (ZODIAC): a double-blind, randomised, phase 3 trial |
scientific article published on July 2010 |
Statements
1 reference
Vandetanib plus docetaxel versus docetaxel as second-line treatment for patients with advanced non-small-cell lung cancer (ZODIAC): a double-blind, randomised, phase 3 trial (English)
1 reference
John V Heymach
1 reference
Roy S Herbst
1 reference
Yan Sun
1 reference
Wilfried E E Eberhardt
1 reference
Paul Germonpré
1 reference
Nagahiro Saijo
1 reference
Caicun Zhou
1 reference
Jie Wang
1 reference
Longyun Li
1 reference
Fairooz Kabbinavar
1 reference
Yukito Ichinose
1 reference
Shukui Qin
1 reference
Li Zhang
1 reference
Bonne Biesma
1 reference
Peter Langmuir
1 reference
Sarah J Kennedy
1 reference
Hiroomi Tada
1 reference
Bruce E Johnson
1 reference
1 reference
1 reference
Identifiers
1 reference